Reduction in CD4 Central Memory T-Cell Subset in Costimulation Modulator Abatacept-Treated Patients With Recent-Onset Type 1 Diabetes Is Associated With Slower C-Peptide Decline

We previously reported that continuous 24-month costimulation blockade by abatacept significantly slows the decline of β-cell function after diagnosis of type 1 diabetes. In a mechanistic extension of that study, we evaluated peripheral blood immune cell subsets (CD4, CD8-naive, memory and activated...

Descripción completa

Detalles Bibliográficos
Autores principales: Orban, Tihamer, Beam, Craig A., Xu, Ping, Moore, Keith, Jiang, Qi, Deng, Jun, Muller, Sarah, Gottlieb, Peter, Spain, Lisa, Peakman, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2014
Materias:
Immunology and Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4171657/
https://www.ncbi.nlm.nih.gov/pubmed/24834977
http://dx.doi.org/10.2337/db14-0047

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4171657/
https://www.ncbi.nlm.nih.gov/pubmed/24834977
http://dx.doi.org/10.2337/db14-0047

Ejemplares similares